 | Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence... 9 KB (878 words) - 12:14, 6 March 2024 |
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus... 192 KB (21,930 words) - 19:29, 15 April 2024 |
treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020). The Inovio technology is based on inserting... 20 KB (1,933 words) - 09:17, 9 June 2023 |
| COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy... 98 KB (20,593 words) - 02:58, 8 March 2024 |
 | papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either... 179 KB (17,071 words) - 18:26, 18 April 2024 |
 | Operation Warp Speed (redirect from Trump vaccine) and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The first news report of Operation... 72 KB (5,994 words) - 15:49, 8 February 2024 |
 | Separately, Inovio Pharmaceuticals and GeneOne Life Science began tests of a different DNA vaccine against Zika in Miami. Manufacturing the vaccines in volume... 139 KB (14,389 words) - 19:40, 15 April 2024 |
| Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed... 29 KB (2,874 words) - 18:05, 19 February 2024 |
The COVID-19 pandemic in Nepal is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2... 181 KB (23,901 words) - 14:23, 6 January 2024 |
 | Vaxart (category COVID-19 vaccine producers) as Novavax, Inovio Pharmaceuticals, and Moderna. In February 2020, Vaxart began a program to develop an oral tablet vaccine for COVID-19. In April, the... 18 KB (1,835 words) - 22:27, 29 March 2024 |
 | AstraZeneca (category COVID-19 vaccine producers) inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish... 85 KB (7,811 words) - 21:10, 17 April 2024 |
 | Coalition for Epidemic Preparedness Innovations (category Organizations associated with the COVID-19 pandemic) working on a vaccine for SARS-CoV-2, being: Moderna, Inovio Pharmaceuticals, and the University of Queensland (UQ). By February 2020, Inovio announced that... 56 KB (5,131 words) - 09:16, 18 April 2024 |
 | Adenovirus vaccine COVID-19 vaccine (Part of today's pandemic since 2019) Coxsackie B virus vaccine Cytomegalovirus vaccine Chikungunya vaccine Eastern Equine... 34 KB (2,305 words) - 03:06, 24 December 2023 |
Inovio could be tested in humans by end of year". Philadelphia Business Journal. January 9, 2013. Retrieved April 24, 2013. "Human hookworm vaccine trial"... 75 KB (1,751 words) - 17:17, 26 March 2024 |
 | Bill & Melinda Gates Foundation (section COVID-19) Varshney, Neer (April 27, 2020). "Bill Gates, Backer of Inovio And Six Others, Says Coronavirus Vaccine Could Be Mass Produced Within A Year". Yahoo! Finance... 141 KB (12,838 words) - 19:30, 6 April 2024 |
 | Separately, Inovio Pharmaceuticals and GeneOne Life Science began tests of a different DNA vaccine against Zika in Miami. The NIH vaccine is injected... 77 KB (8,381 words) - 08:06, 22 February 2024 |
 | News. 2020-06-29. Retrieved 2020-07-01. "INOVIO Reports Positive Interim Phase I Data for COVID-19 DNA Vaccine, Joins "Warp Speed" Primate Study". Genetic... 53 KB (5,336 words) - 23:10, 8 March 2024 |
in this trial are “a protein subunit vaccine from Medigen, and a DNA vaccine encoding the spike protein from Inovio.” More countries are expected to join... 142 KB (14,911 words) - 10:52, 18 April 2024 |
 | July 26, 2016, Inovio Pharmaceuticals, Inc. dosed the first subject in its multi-center phase I trial to evaluate Inovio's Zika DNA vaccine (GLS-5700). In... 161 KB (12,816 words) - 22:55, 18 April 2024 |
from the original on 16 August 2017. Retrieved 27 August 2017. "Vaccine Pioneer Joins Inovio Biomedical's Scientific Advisory Board". Invoio Pharmaceuticals... 26 KB (1,245 words) - 08:11, 1 February 2024 |